Scarica l'app Stockscreener
36.81
3.28%
-1.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$38.06
Aprire:
$37.63
Volume 24 ore:
174.91K
Relative Volume:
0.46
Capitalizzazione di mercato:
$681.06M
Reddito:
$299.77M
Utile/perdita netta:
$364.23M
Rapporto P/E:
1.9662
EPS:
18.7211
Flusso di cassa netto:
$79.27M
1 W Prestazione:
+0.19%
1M Prestazione:
-5.90%
6M Prestazione:
+5.59%
1 anno Prestazione:
+74.79%
Intervallo 1D:
$36.14
$37.83
Intervallo di 1 settimana:
$36.14
$39.95
Portata 52W:
$20.28
$52.24
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Nome
Rigel Pharmaceuticals
Settore
Industria
Telefono
650-624-1100
Indirizzo
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Compare RIGL vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
36.81 | 691.79M | 299.77M | 364.23M | 79.27M | 18.72 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-04-03 | Ripresa | Piper Sandler | Neutral |
| 2022-06-09 | Downgrade | Citigroup | Buy → Neutral |
| 2022-06-08 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | Iniziato | B. Riley Securities | Neutral |
| 2020-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-11-15 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-09-26 | Ripresa | JP Morgan | Overweight |
| 2019-03-01 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-08-27 | Iniziato | Citigroup | Buy |
| 2018-05-02 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Ripresa | Piper Jaffray | Overweight |
| 2017-12-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-11-06 | Ripresa | H.C. Wainwright | Buy |
| 2017-03-09 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-31 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-30 | Reiterato | Piper Jaffray | Overweight |
| 2016-07-13 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-13 | Iniziato | Piper Jaffray | Overweight |
| 2016-04-22 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2013-04-08 | Reiterato | Stifel | Buy |
| 2012-11-29 | Iniziato | UBS | Neutral |
| 2012-11-06 | Reiterato | Oppenheimer | Outperform |
| 2012-03-26 | Iniziato | Canaccord Genuity | Hold |
| 2010-12-10 | Downgrade | MP Advisors | Outperform → Market Perform |
Mostra tutto
Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie
Rigel schedules a live webcast for its Aug. 4 business update - Stock Titan
Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results - 富途牛牛
Rigel Pharmaceuticals Inc (RIGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rigel Pharmaceuticals Inc (RIGL) Balance Sheet - TradingKey
Rigel Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:RIGL - TradingView
Rigel Pharmaceuticals Inc (RIGL) Cash Flow - TradingKey
Rigel Pharmaceuticals Inc (RIGL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Rigel Pharmaceuticals Inc (RIGL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
RIGL|Rigel Pharmaceuticals Inc|Price:37.520|Chg%:+0.780 - TradingKey
TradingKey - TradingKey
Rigel Pharmaceuticals, Inc. Revenue Breakdown – MUN:RI2 - TradingView
Rigel Pharmaceuticals (RIGL) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Up and down the ladder: The latest comings and goings - STAT
Rigel Pharmaceuticals Inc (RIGL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RIGEL PHARMACEUTICALS INC (RIGL) Stock Chart - ChartMill
(RIGL) Risk Channels and Responsive Allocation - Stock Traders Daily
RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside? - Stocktwits
Rigel Pharmaceuticals Inc (RIGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rigel Pharmaceuticals (RIGL) Slips 2.94% as Selling Pressure Tests Key Support LevelsTrend Reversal Picks - dars.gov.et
Rigel Pharmaceuticals Holds Steady Near Resistance as Biotech Sector WatchesImpulse Wave - dars.gov.et
Form 4 Rigel Pharmaceuticals Inc For: 10 July By Investing.com - Investing.com Australia
Rigel Pharmaceuticals (RIGL) CMO receives 24,400-share RSU equity award with 4-year vesting - Stock Titan
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - AOL.com
Rigel Pharmaceuticals (RIGL) Investor update Summary - Quartr
Rigel Pharmaceuticals (RIGL) Q1 2026 earnings summary - Quartr
Rigel Pharmaceuticals (RIGL) Corporate presentation Summary - Quartr
Rigel Pharmaceuticals (RIGL) Proxy filing Summary - Quartr
Rigel Pharmaceuticals (RIGL) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Rigel Pharmaceuticals, Inc. Announces Inducem - Moomoo
Rigel Pharmaceuticals, Inc. (RIGL) Latest Stock News & Headlines - Yahoo Finance
Rigel awards new hires 13,375 RSUs under its inducement plan - Stock Titan
RI2 Forecast — Price Target — Prediction for 2027 - TradingView
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer - Sahm
Rigel appoints Alison L Hannah as chief medical officer - MSN
Rigel Pharmaceuticals, Inc. Files 8-K With SEC: Corporate Details, Stock Info, and Compliance Updates - Minichart
Alison Hannah joins Rigel (NASDAQ: RIGL) as new EVP and Chief Medical Officer - Stock Titan
Rigel Pharmaceuticals Appoints Dr. Alison L. Hannah as CMO (RIGL) - GuruFocus
Rigel Pharmaceuticals Appoints Alison L. Hannah as Chief Medical Officer - citybiz
Press Release: Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer - Moomoo
Rigel Pharmaceuticals appoints Dr. Alison Hanna... - Pluang
(RIGL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
RIGL Q1 2026 Earnings: EPS Misses Estimates, Revenue Not Disclosed, Stock Edges HigherRetail Earnings Report - dars.gov.et
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) added to Russell Microcap Value Benchmark Index - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS: RIGL) added to Russell 2000 Value Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – BX:RIGL - TradingView
Rigel Pharmaceuticals Azioni (RIGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):